Stock Market Updates · Portfolio Strategy

The Real Concentration Risk Isn't "US vs. International" — It's AI vs. Everything Else

By Luke  |  EverHealthAI  |  June 2026

Investors worried about AI-driven concentration in their portfolios have been reaching for an instinctive solution: diversify out of the U.S. and into emerging markets. That instinct is understandable, and it is also largely wrong — because the real axis of risk in global equity markets right now isn't geography. It's exposure to a single theme.

Consider South Korea's SK Hynix, which in May accounted for nearly 8% of the entire return generated by every stock market in the world combined. That is not a typo, and it is not an isolated case. Taiwan's semiconductor exposure tells a similar story. Emerging markets, often pitched as the natural counterweight to U.S. overconcentration, are in many cases just as levered to the AI cycle as the S&P 500 — sometimes more so, given how concentrated their indices are around a handful of chip and hardware names.

If the goal is genuine diversification away from AI-cycle risk, the more useful question isn't "U.S. or international." It's "which markets have meaningfully different sector composition and capital allocation behavior than the AI-driven names dominating global indices." On that question, Europe stands out — not as a safer bet, but as a genuinely different one.

The Concentration Math Is Not Subtle

The numbers describing U.S. index concentration are worth sitting with rather than skimming past. In a standard S&P 500 index fund, technology and communications sectors combined account for nearly half of total assets. A single company — Nvidia — represents close to 8% of the index on its own. And the index as a whole trades at roughly 41 times long-term, inflation-adjusted earnings, approaching levels last seen at the peak of the dot-com era.

That is not inherently a problem. As the historical evidence on index concentration shows, a handful of dominant companies has not been a reliable predictor of poor forward returns. But concentration does change the character of risk. When nearly half of an index's value depends on the continued strength of a single technological narrative, the index's risk profile becomes a bet on that narrative, whether or not individual investors intended to make that bet.

Europe's index composition looks structurally different. The largest company in the MSCI Europe index, ASML, represents about 5% of the index — roughly the weight of Nvidia alone in the S&P 500, but as the largest position rather than one of several mega-cap concentrations. Technology overall makes up roughly 10% of the European index, about a quarter of its U.S. weighting. The largest sectors in Europe are financials, industrials, and healthcare — sectors tied to credit cycles, industrial demand, and demographic healthcare spending rather than AI capital expenditure cycles.

The Valuation Gap: Cheap, But Cheap for Reasons That Matter

European equities trade at under 23 times long-term inflation-adjusted earnings — roughly half the U.S. multiple, and notably below where European valuations stood five years ago. That gap did not appear overnight. Over the past decade, U.S. equities have outperformed European equities by more than 150 percentage points, a divergence driven by exactly the dynamics now causing concentration concerns: American technology companies captured an outsized share of global growth, global capital, and global investor attention.

The honest framing is that Europe is cheap for legitimate structural reasons. An aging population, heavier debt burdens, slower productivity growth, energy import dependency, and a regulatory environment less conducive to rapid scaling — these are real headwinds, not market overreactions waiting to be corrected.

What the Market May Be Underestimating

The dominant narrative around European equities treats the region's problems as a permanent ceiling on returns — Europe as a value trap, perpetually cheap because it deserves to be cheap. That narrative may be missing two things.

First, low expectations create asymmetric outcomes. When a market has been written off to the point that nearly $500 million has flowed out of European equity ETFs this year alone, the bar for positive surprise drops considerably. Markets pricing in stagnation don't need transformation to outperform — they need results that are merely less bad than expected.

Second, there is emerging evidence of operational change inside major European companies that the market may not have fully absorbed. Investment managers with direct exposure to European corporate restructuring describe the current pace of efficiency improvements as unusually aggressive by historical standards. If European corporates are genuinely improving margins from a depressed valuation base, that combination — improving fundamentals plus compressed multiples — is precisely the setup that has historically preceded periods of relative outperformance, even within structurally challenged economies.

The Diversification Logic, Properly Understood

The case for adding European exposure is not that Europe will outperform if the AI boom continues — it almost certainly won't, by the same logic that has driven the past decade of underperformance. The case is that European equities are likely to behave differently if the AI narrative falters.

Higher dividend yields provide a cash-flow cushion that doesn't depend on growth expectations being met. Lower valuations mean less embedded "story premium" that would need to unwind in a correction. Different sector composition means European indices aren't making the same implicit bet on AI capital expenditure translating into AI revenue that dominates U.S. and many emerging-market indices.

None of this makes Europe "safe." Europe carries its own tail risks — a deepening conflict in Eastern Europe, energy price shocks from Middle East disruptions, renewed transatlantic tariff escalation, or a sharp dollar move against the euro could all hit European equities hard, in some scenarios harder than U.S. equities. The point of diversification was never to find an asset immune to risk. It's to hold assets whose risks are different enough from each other that they don't all materialize from the same trigger at the same time.

Cyclical or Structural?

Both, but in different layers. Europe's structural challenges — demographics, debt, energy dependency, productivity growth — are not cyclical and will not resolve on any near-term timeline. They are legitimate, durable headwinds priced into the region's persistent valuation discount.

But the relative positioning of Europe versus AI-concentrated markets is more cyclical than it appears. The current valuation gap reflects a decade in which capital chased a specific growth narrative with extraordinary conviction. If that conviction wavers — even temporarily, even without the AI thesis being proven wrong — capital reallocation toward cheaper, less-concentrated, higher-yielding alternatives tends to happen quickly. That reallocation dynamic is cyclical, even if the underlying structural gap between U.S. and European fundamentals persists.

What to Watch Next

The question investors should be asking isn't whether Europe is a good place to hide from an AI bubble. It's whether their portfolios currently hold assets that would behave differently from each other if the AI narrative changes — in either direction. For many investors heavily weighted toward U.S. and AI-exposed emerging market equities, the honest answer is probably no. Europe, with all its acknowledged structural baggage, is one of the few major equity markets currently offering a genuinely different bet.

This article is for informational and educational purposes only. It does not constitute financial or investment advice. Always consult a qualified financial advisor before making investment decisions.